Literature DB >> 29757454

Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Juan Va Franco1, Tarek Turk, Jae Hung Jung, Yu-Tian Xiao, Stanislav Iakhno, Virginia Garrote, Valeria Vietto.   

Abstract

BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder in which the two main clinical features are pelvic pain and lower urinary tract symptoms. There are currently many approaches for its management, using both pharmacological and non-pharmacological interventions. The National Institute of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) score is a validated measure commonly used to measure CP/CPPS symptoms.
OBJECTIVES: To assess the effects of non-pharmacological therapies for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). SEARCH
METHODS: We performed a comprehensive search using multiple databases, trial registries, grey literature and conference proceedings with no restrictions on the language of publication or publication status. The date of the latest search of all databases was August 2017. SELECTION CRITERIA: We included randomised controlled trials. Inclusion criteria were men with a diagnosis of CP/CPPS. We included all available non-pharmacological interventions. DATA COLLECTION AND ANALYSIS: Two review authors independently classified studies and abstracted data from the included studies, performed statistical analyses and rated quality of evidence (QoE) according to the GRADE methods. MAIN
RESULTS: We included 38 unique studies with 3290 men with CP/CPPS across 23 comparisons.1. Acupuncture: (three studies, 204 participants) based on short-term follow-up, acupuncture probably leads to clinically meaningful reduction in prostatitis symptoms compared with sham procedure (mean difference (MD) in total NIH-CPSI score -5.79, 95% confidence interval (CI) -7.32 to -4.26, high QoE). Acupuncture may result in little to no difference in adverse events (low QoE). Acupuncture may not reduce sexual dysfunction when compared with sham procedure (MD in the International Index of Erectile Function (IIEF) Scale -0.50, 95% CI -3.46 to 2.46, low QoE). Acupuncture may also lead to a clinically meaningful reduction in prostatitis symptoms compared with standard medical therapy (MD -6.05, 95% CI -7.87 to -4.24, two studies, 78 participants, low QoE). We found no information regarding quality of life, depression or anxiety.2. Lifestyle modifications: (one study, 100 participants) based on short-term follow-up, lifestyle modifications may be associated with a reduction in prostatitis symptoms compared with control (risk ratio (RR) for improvement in NIH-CPSI scores 3.90, 95% CI 2.20 to 6.92, very low QoE). We found no information regarding adverse events, sexual dysfunction, quality of life, depression or anxiety.3. Physical activity: (one study, 85 participants) based on short-term follow-up, a physical activity programme may cause a small reduction in prostatitis symptoms compared with control (NIH-CPSI score MD -2.50, 95% CI -4.69 to -0.31, low QoE). This programme may not reduce anxiety or depression (low QoE). We found no information regarding adverse events, sexual dysfunction or quality of life.4. Prostatic massage: (two studies, 115 participants) based on short-term follow-up, we are uncertain whether the prostatic massage reduces or increases prostatitis symptoms compared with control (very low QoE). We found no information regarding adverse events, sexual dysfunction, quality of life, depression or anxiety.5. Extracorporeal shockwave therapy: (three studies, 157 participants) based on short-term follow-up, extracorporeal shockwave therapy reduces prostatitis symptoms compared with control (NIH-CPSI score MD -6.18, 95% CI -7.46 to -4.89, high QoE). These results may not be sustained at medium-term follow-up (low QoE). This treatment may not be associated with a greater incidence of adverse events (low QoE). This treatment probably improves sexual dysfunction (MD in the IIEF Scale MD 3.34, 95% CI 2.68 to 4.00, one study, 60 participants, moderate QoE). We found no information regarding quality of life, depression or anxiety.6. Transrectal thermotherapy compared to medical therapy: (two studies, 237 participants) based on short-term follow-up, transrectal thermotherapy alone or in combination with medical therapy may decrease prostatitis symptoms slightly when compared with medical therapy alone (NIH-CPSI score MD -2.50, 95% CI -3.82 to -1.18, low QoE). One included study reported that participants may experience transient adverse events. We found no information regarding sexual dysfunction, quality of life, depression or anxiety.7. Other interventions: there is uncertainty about the effects of most of the other interventions included in this review. We found no information regarding psychological support or prostatic surgery. AUTHORS'
CONCLUSIONS: Based on the findings of moderate quality evidence, this review found that some non-pharmacological interventions such as acupuncture and extracorporeal shockwave therapy are likely to result in a decrease in prostatitis symptoms and may not be associated with a greater incidence of adverse event. The QoE for most other comparisons was predominantly low. Future clinical trials should include a full report of their methods including adequate masking, consistent assessment of all patient-important outcomes including potential treatment-related adverse events and appropriate sample sizes.

Entities:  

Mesh:

Year:  2018        PMID: 29757454      PMCID: PMC6494451          DOI: 10.1002/14651858.CD012551.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  156 in total

1.  [Clinical trials of combined therapy of an oral Chinese medicine with massage for chronic nonbacterial prostatitis].

Authors:  Shu-lin Shen; Da-lin He; Yong Luo
Journal:  Zhonghua Nan Ke Xue       Date:  2006-09

Review 2.  Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.

Authors:  Thunyarat Anothaisintawee; John Attia; J Curtis Nickel; Sangsuree Thammakraisorn; Pawin Numthavaj; Mark McEvoy; Ammarin Thakkinstian
Journal:  JAMA       Date:  2011-01-05       Impact factor: 56.272

3.  Does Greenlight HPS(™) laser photoselective vaporization prostatectomy affect sexual function?

Authors:  Massimiliano Spaliviero; Kurt H Strom; Xiao Gu; Motoo Araki; Daniel J Culkin; Carson Wong
Journal:  J Endourol       Date:  2010-10-21       Impact factor: 2.942

Review 4.  Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units.

Authors:  Bradley C Johnston; Kristian Thorlund; Holger J Schünemann; Feng Xie; Mohammad Hassan Murad; Victor M Montori; Gordon H Guyatt
Journal:  Health Qual Life Outcomes       Date:  2010-10-11       Impact factor: 3.186

5.  [Long-term effects of osteopathic treatment of chronic prostatitis with chronic pelvic pain syndrome: a 5-year follow-up of a randomized controlled trial and considerations on the pathophysiological context].

Authors:  S Marx; U Cimniak; M Rütz; K L Resch
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

6.  Lower urinary tract symptoms, pain and quality of life assessment in chronic non-bacterial prostatitis patients treated with alpha-blocking agent doxazosin; versus placebo.

Authors:  Yalçin Evliyaoğlu; Refik Burgut
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

7.  Is there a role for transrectal microwave hyperthermia of the prostate in the treatment of abacterial prostatitis and prostatodynia?

Authors:  F Montorsi; G Guazzoni; F Bergamaschi; L Galli; P Consonni; V Matozzo; L Barbieri; P Rigatti
Journal:  Prostate       Date:  1993       Impact factor: 4.104

8.  Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.

Authors:  Daniel A Shoskes; Qussay Albakri; Kim Thomas; Daniel Cook
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

9.  A prospective interventional study in chronic prostatitis with emphasis to clinical features.

Authors:  Konstantinos Nikolaos Stamatiou; Hippocrates Moschouris
Journal:  Urol J       Date:  2014-09-06       Impact factor: 1.510

10.  Minimal clinically important difference on the Beck Depression Inventory--II according to the patient's perspective.

Authors:  K S Button; D Kounali; L Thomas; N J Wiles; T J Peters; N J Welton; A E Ades; G Lewis
Journal:  Psychol Med       Date:  2015-07-13       Impact factor: 7.723

View more
  14 in total

1.  Cochrane reviews on acupuncture therapy for pain: A snapshot of the current evidence.

Authors:  Arya Nielsen; L Susan Wieland
Journal:  Explore (NY)       Date:  2019-09-12       Impact factor: 1.775

Review 2.  The efficacy and safety of low-intensity extracorporeal shock wave treatment combined with or without medications in Chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.

Authors:  Xiangbin Kong; Weiwei Hu; Zhilong Dong; Junqiang Tian; Yuhan Wang; Chen Jin; Chaozhao Liang; Zongyao Hao; Zhiping Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-07-07       Impact factor: 5.554

Review 3.  Does TENS Reduce the Intensity of Acute and Chronic Pain? A Comprehensive Appraisal of the Characteristics and Outcomes of 169 Reviews and 49 Meta-Analyses.

Authors:  Carole A Paley; Priscilla G Wittkopf; Gareth Jones; Mark I Johnson
Journal:  Medicina (Kaunas)       Date:  2021-10-04       Impact factor: 2.430

4.  Acupuncture as Part of Multimodal Analgesia for Chronic Pain.

Authors:  Christopher L Robinson; Amnon Berger; Emily Sottosanti; Michael Li; Alicia Kaneb; Joseph Keefe; Edward Kim; Alan Kaye; Omar Viswanath; Ivan Urits
Journal:  Orthop Rev (Pavia)       Date:  2022-09-23

Review 5.  Effectiveness of Myofascial Manual Therapies in Chronic Pelvic Pain Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Fulvio Dal Farra; Alessandro Aquino; Andrea Gianmaria Tarantino; Daniele Origo
Journal:  Int Urogynecol J       Date:  2022-04-07       Impact factor: 1.932

6.  Effectiveness and Safety of Umbilicus Treatment with Modified Dinggui Powder () in Patients with Chronic Nonbacterial Prostatitis: A Randomized, Double-blind, Placebo-controlled Clinical Trial.

Authors:  Hai Huang; Min-Jie Zhou; Ke-Xie Wang; Chao Yu; Yu-Hang Wang; Jun Ji; Wen Pan; Jian Ying; Ling Zhao
Journal:  Chin J Integr Med       Date:  2020-04-01       Impact factor: 1.978

7.  Extracellular vesicles released from hiPSC-derived MSCs attenuate chronic prostatitis/chronic pelvic pain syndrome in rats by immunoregulation.

Authors:  Xufeng Peng; Hailin Guo; Ji Yuan; Yu Chen; Yuguo Xia; Lin Wang; Ying Wang; Yichen Huang; Hua Xie; Yang Wang; Fang Chen
Journal:  Stem Cell Res Ther       Date:  2021-03-20       Impact factor: 6.832

8.  Determinants of Self-reported Health Outcomes in Adrenal Insufficiency: A Multisite Survey Study.

Authors:  Dingfeng Li; Natalia Genere; Emma Behnken; Majlinda Xhikola; Tiffany Abbondanza; Anand Vaidya; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 9.  Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Juan Va Franco; Tarek Turk; Jae Hung Jung; Yu-Tian Xiao; Stanislav Iakhno; Federico Ignacio Tirapegui; Virginia Garrote; Valeria Vietto
Journal:  Cochrane Database Syst Rev       Date:  2019-10-06

10.  Comparison of 3 assessment modes of acupuncture effect on patients with chronic prostatitis/chronic pelvic pain syndrome: A study protocol for a randomized controlled trial.

Authors:  Jing Zhou; Yan Liu; Chunbin Li; Zhishun Liu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.